Incidence and risk factors of toxoplasmosis in a cohort of human immunodeficiency virus-infected patients: 1988-1995. HEMOCO and SEROCO Study Groups.
about
Immunoblot profile as predictor of toxoplasmic encephalitis in patients infected with human immunodeficiency virusMetabolic reconstruction identifies strain-specific regulation of virulence in Toxoplasma gondii.Diarrhea as a Presenting Symptom of Disseminated ToxoplasmosisLack of utility of specific immunoglobulin G antibody avidity for serodiagnosis of reactivated toxoplasmosis in immunocompromised patients.Arboprotozoae.Parasitic infections in HIV infected individuals: diagnostic & therapeutic challengesToxoplasma encephalitis in HIV/AIDS patients admitted to the Douala general hospital between 2004 and 2009: a cross sectional studySeroprevalence of Toxoplasma gondii infection in pet dogs in Lanzhou, Northwest China.Disseminated toxoplasmosis in a patient with undiagnosed AIDSIdentification of functional modules of AKMT, a novel lysine methyltransferase regulating the motility of Toxoplasma gondii.The origins of apicomplexan sequence innovation.Other HIV-associated pneumonias.Toxoplasma encephalitis in AIDS patients in São Paulo during 1988 and 1991. A comparative retrospective analysis.Disseminated toxoplasmosis following T cell-depleted related and unrelated bone marrow transplantation.The prevalence of antibodies to Toxoplasma gondii in horses in Changji Hui Autonomous Prefecture, Xinjiang, northwestern China.Polymerase chain reaction based detection of Toxoplasma gondii from lymph node aspirates of dogs.Reactivation of retinal toxoplasmosis despite evidence of immune response to highly active antiretroviral therapy.Features to validate cerebral toxoplasmosis.Neurotoxicity and immunotoxicity assessment in CBA/J mice with chronic Toxoplasma gondii infection and single-dose exposure to methylmercury.Incidence and risk factors for toxoplasmic encephalitis in human immunodeficiency virus-infected patients before and during the highly active antiretroviral therapy era.High seroprevalence of antibodies to Toxoplasma gondii in wild animals from Portugal.Serological survey of Toxoplasma gondii infection in the domestic goose (Anser domestica) in southern ChinaToxoplasmosis after hematopoietic stem transplantation. Report of a 5-year survey from the Infectious Diseases Working Party of the European Group for Blood and Marrow Transplantation
P2860
Q28364021-F591979F-95CC-4B38-8A5F-C64A080979DDQ33689651-543F62D5-F947-446A-ADCC-A9F14B30580AQ33868060-C05974F7-0033-4003-BB95-D7FF7A9E50AEQ33998548-137CBE02-625E-4EAF-B38A-C58F68B0CAAFQ34086340-6D688650-BE8A-47E1-AFA4-3ED249627772Q34635675-893FD7F2-6870-4EBF-B696-6D9CAE816202Q34669072-D1B0280D-38B1-4908-9BCA-EC2FC322EE61Q35027165-C6AB917B-8C4B-4A32-A411-E1C28B323D43Q37061005-ED513E9C-9F6D-46BC-8FCD-B196B4C62C9EQ37086743-07D6C148-353D-42DE-86CE-C0550289EDB1Q37247038-62AD87C6-61D6-4A80-A494-00697A706AA1Q37552818-EFAF27B4-46DB-47BC-B9ED-FC68A8A5EE9FQ40618750-F1386E53-4847-40AD-9414-352E15AAC9AFQ40621934-2CF5AEAF-F440-4676-92B0-E4BAF08D4665Q41020084-0E92E1F6-A935-45EE-8098-9888446FC80CQ41776258-0512A3EF-8A2A-48A2-B11E-68D87E68CA9AQ44081435-125D304B-6442-4004-9775-9A7A37BF3D7CQ44148675-ED16BDED-7859-4B6A-8343-F374E08784CAQ44892140-EEE0832F-4514-432F-A301-EF1137069E71Q45735357-19C65F93-D03E-4979-B449-ADA2A7693A1FQ50554003-60B5D567-4BBE-45B3-BDDB-E5D3F97CF369Q56770165-0A36113B-3657-43D7-83CB-9B64B5C96379Q56838505-ADF25606-91D3-41E7-9490-518467FEB709
P2860
Incidence and risk factors of toxoplasmosis in a cohort of human immunodeficiency virus-infected patients: 1988-1995. HEMOCO and SEROCO Study Groups.
description
1999 nî lūn-bûn
@nan
1999年の論文
@ja
1999年学术文章
@wuu
1999年学术文章
@zh
1999年学术文章
@zh-cn
1999年学术文章
@zh-hans
1999年学术文章
@zh-my
1999年学术文章
@zh-sg
1999年學術文章
@yue
1999年學術文章
@zh-hant
name
Incidence and risk factors of ...... EMOCO and SEROCO Study Groups.
@en
Incidence and risk factors of ...... EMOCO and SEROCO Study Groups.
@nl
type
label
Incidence and risk factors of ...... EMOCO and SEROCO Study Groups.
@en
Incidence and risk factors of ...... EMOCO and SEROCO Study Groups.
@nl
prefLabel
Incidence and risk factors of ...... EMOCO and SEROCO Study Groups.
@en
Incidence and risk factors of ...... EMOCO and SEROCO Study Groups.
@nl
P2093
P356
P1476
Incidence and risk factors of ...... EMOCO and SEROCO Study Groups.
@en
P2093
Belanger F
Grangeot-Keros L
P304
P356
10.1086/515147
P407
P577
1999-03-01T00:00:00Z